N4 Pharma Plc (LON:N4P – Get Free Report) was down 7.7% during trading on Tuesday . The company traded as low as GBX 0.55 ($0.01) and last traded at GBX 0.60 ($0.01). Approximately 432,387 shares changed hands during trading, a decline of 64% from the average daily volume of 1,201,942 shares. The stock had previously closed at GBX 0.65 ($0.01).
N4 Pharma Stock Down 7.7 %
The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The stock has a market capitalization of £2.37 million, a P/E ratio of -55.00 and a beta of -0.37. The stock’s 50 day simple moving average is GBX 0.63 and its 200 day simple moving average is GBX 0.58.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Further Reading
- Five stocks we like better than N4 Pharma
- Ride Out The Recession With These Dividend Kings
- Cerence Up 155% in 2 Days: SoundHound AI’s Fierce Competitor
- What is the Dogs of the Dow Strategy? Overview and Examples
- Why Warren Buffett Is Selling: A Look at His Latest Market Moves
- The 3 Best Fintech Stocks to Buy Now
- Why Amazon Shares May Never Trade Below $200 Again
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
